Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
2021 · New England Journal of Medicine · 884 citations
https://doi.org/10.1056/nejmoa2034975
G
Gene Colice
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
315
Papers
11.3K
Citations
53
h-index
155
i10-index
Gene Colice is an academic researcher from AstraZeneca (United States). The author has contributed to research in topics: Asthma and respiratory diseases & Inhalation and Respiratory Drug Delivery & Respiratory and Cough-Related Research. The author has an h-index of 53, co-authored 268 publications.
Papers by this author
worksNAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
2020 · Respiratory Research · 108 citations
https://doi.org/10.1186/s12931-020-01526-6
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma
2020 · Respiratory Research · 86 citations
https://doi.org/10.1186/s12931-020-01503-z
Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review
2018 · Drug Safety · 74 citations
https://doi.org/10.1007/s40264-017-0636-9
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
2020 · Respiratory Research · 65 citations
https://doi.org/10.1186/s12931-020-01541-7
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma
2019 · Drug Safety · 18 citations
https://doi.org/10.1007/s40264-018-00788-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat